Database: NCZI Cancer Registry (Slovakia): Difference between revisions

From Beacon
(Created page with "{{#subobject:NCZI Cancer Registry |dct:title=NCZI Cancer Registry |datatype=registry }} '''Sponsor, manager or home institution:''' Národné centrum zdravotníckych informácií. '''Primary purpose:''' to provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities. '...")
 
No edit summary
Line 1: Line 1:
{{#subobject:NCZI Cancer Registry
'''Sponsor, manager or home institution:''' [[dataOwner::Národné centrum zdravotníckych informácií]].
|dct:title=NCZI Cancer Registry
|datatype=registry
}}


'''Sponsor, manager or home institution:''' Národné centrum zdravotníckych informácií.
'''Primary purpose:''' To provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.
 
'''Primary purpose:''' to provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.


'''Type of information:''' No data dictionary was found for this database.
'''Type of information:''' No data dictionary was found for this database.


'''Available type of information:''' Estimated incidence of malignant tumors and incidence indicators according to diagnosis; Gender; Year; Age group; Territory and stage [https://iszi.nczisk.sk/nor.sr/incidencia].
'''Available type of information:''' Estimated [[availableVariable:: cancer incidence]] and incidence indicators according to [[availableVariable::diagnosis]]; [[availableVariable::sex]]; [[availableVariable::year]]; [[availableVariable::age]] group; [[availableVariable::region]] and [[availableVariable::tumor staging]] [https://iszi.nczisk.sk/nor.sr/incidencia].


'''Source of Information:''' Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.
'''Source of Information:''' Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.


'''Data level:''' Patient level.
'''Data level:''' [[dataLevel::patient level]].


'''Available data level:''' Regional level.
'''Available data level:''' [[availableDataLevel::regional level]].


'''Number of Records:''' Unknown.
'''Number of Records:''' [[numberRecords::unknown]].


'''Date Range:''' 1997 to 2012.
'''Date Range:''' [[dataStart::1997]] [[dataEnd::2012]].


'''Cancer Areas of Interest:''' Malignant tumors and carcinomas in situ (C00-C96, D00-D09); Lips, oral cavity and pharynx (C00 – C14); digestive organs (C15 – C26); Respiratory and intrathoracic organs (C30 – C39); Bones and articular cartilage (C40 – C41); Melanoma and other skin cancers (C43 – C44); Mesothelium and soft tissue (C45 – C49); Breast (C50); Female genital organs (C51 – C58); Male genitalia (C60 – C63); Urinary system (C64 – C68); Eye, brain and other parts of the CNS (C69 – C72); Thyroid and other endocrine glands (C73-C75); Imprecisely determined, secondary and non-specific locations (C76 – C80); Lymphatic, hematopoietic and related tissue (C81 – C96); Carcinomas in situ (D00 – D09).
'''Cancer Areas of Interest:''' [[hasCancerAreasList::malignant tumors and carcinomas in situ (C00-C96, D00-D09)]]; Lips, oral cavity and pharynx (C00 – C14); digestive organs (C15 – C26); Respiratory and intrathoracic organs (C30 – C39); Bones and articular cartilage (C40 – C41); Melanoma and other skin cancers (C43 – C44); Mesothelium and soft tissue (C45 – C49); Breast (C50); Female genital organs (C51 – C58); Male genitalia (C60 – C63); Urinary system (C64 – C68); Eye, brain and other parts of the CNS (C69 – C72); Thyroid and other endocrine glands (C73-C75); Imprecisely determined, secondary and non-specific locations (C76 – C80); Lymphatic, hematopoietic and related tissue (C81 – C96); Carcinomas in situ (D00 – D09).


'''Data access:''' Partially publicly available [https://iszi.nczisk.sk/nor.sr/uvod]. Instructions to request data for restricted content [https://iszi.nczisk.sk/nor.sr/kontakt].
'''Data access:''' [[dataAvailability::partially publicly available]] [https://iszi.nczisk.sk/nor.sr/uvod]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://iszi.nczisk.sk/nor.sr/kontakt]]].


'''Contact information:''' Information [https://iszi.nczisk.sk/nor.sr/kontakt].
'''Contact information:''' Information [https://iszi.nczisk.sk/nor.sr/kontakt].

Revision as of 15:57, 16 November 2023

Sponsor, manager or home institution: Národné centrum zdravotníckych informácií.

Primary purpose: To provide comprehensive and accurate information on the occurrence of oncological diseases in a defined population, enabling the evaluation and control of the impact of oncology in the community and informing public health priorities and cancer control activities.

Type of information: No data dictionary was found for this database.

Available type of information: Estimated cancer incidence and incidence indicators according to diagnosis; sex; year; age group; region and tumor staging [1].

Source of Information: Data reported by relevant intelligence units (SJ) and healthcare providers (PZS) who are obligated to report patients with malignant tumors.

Data level: patient level.

Available data level: regional level.

Number of Records: unknown.

Date Range: 1997 2012.

Cancer Areas of Interest: malignant tumors and carcinomas in situ (C00-C96, D00-D09); Lips, oral cavity and pharynx (C00 – C14); digestive organs (C15 – C26); Respiratory and intrathoracic organs (C30 – C39); Bones and articular cartilage (C40 – C41); Melanoma and other skin cancers (C43 – C44); Mesothelium and soft tissue (C45 – C49); Breast (C50); Female genital organs (C51 – C58); Male genitalia (C60 – C63); Urinary system (C64 – C68); Eye, brain and other parts of the CNS (C69 – C72); Thyroid and other endocrine glands (C73-C75); Imprecisely determined, secondary and non-specific locations (C76 – C80); Lymphatic, hematopoietic and related tissue (C81 – C96); Carcinomas in situ (D00 – D09).

Data access: partially publicly available [2]. Instructions to request data for restricted content [3].

Contact information: Information [4].